547 related articles for article (PubMed ID: 25954852)
21. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
22. Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting.
Ge Y; Christensen PA; Luna E; Armylagos D; Xu J; Hsu JW; Zhou H; Schwartz MR; Mody DR
Cancer Cytopathol; 2019 Dec; 127(12):757-764. PubMed ID: 31589379
[TBL] [Abstract][Full Text] [Related]
23. Atypical Squamous Cells of Undetermined Significance Cervical Cytology Report Rate and Histologic Follow-up Findings From the Largest College of American Pathologists-Certified Laboratory in China.
Zheng B; Yang H; Li Z; You J; Wei G; Zhang H; Zeng Z; Xie F; Zhao C
Arch Pathol Lab Med; 2019 Jun; 143(6):748-752. PubMed ID: 30605022
[TBL] [Abstract][Full Text] [Related]
24. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.
Zhao L; Wentzensen N; Zhang RR; Dunn ST; Gold MA; Wang SS; Schiffman M; Walker JL; Zuna RE
Cancer Cytopathol; 2014 Sep; 122(9):694-701. PubMed ID: 24888458
[TBL] [Abstract][Full Text] [Related]
26. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
27. HPV Screening Test for the Detection of Precancerous Cervical Lesions and Cervical Cancer in Israeli Women.
Feinberg T; Yehuda-Shnaidman E; Wolf T; Sandbank J; Segal J; Vaknin Z; Schejter E
Acta Cytol; 2021; 65(6):494-500. PubMed ID: 34515031
[TBL] [Abstract][Full Text] [Related]
28. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
Nishino HT; Tambouret RH; Wilbur DC
Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
[TBL] [Abstract][Full Text] [Related]
29. Surveillance for recurrent cancers and vaginal epithelial lesions in patients with invasive cervical cancer after hysterectomy: are vaginal cytology and high-risk human papillomavirus testing useful?
Li Z; Barron S; Hong W; Karunamurthy A; Zhao C
Am J Clin Pathol; 2013 Nov; 140(5):708-14. PubMed ID: 24124151
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer rates after the transition from annual Pap to 3-year HPV and Pap.
Dinkelspiel H; Fetterman B; Poitras N; Kinney W; Cox JT; Lorey T; Castle PE
J Low Genit Tract Dis; 2014 Jan; 18(1):57-60. PubMed ID: 24022057
[TBL] [Abstract][Full Text] [Related]
32. Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection.
Andersson S; Larson B; Hjerpe A; Silfverswärd C; Sällström J; Wilander E; Rylander E
Acta Obstet Gynecol Scand; 2003 Oct; 82(10):960-5. PubMed ID: 12956848
[TBL] [Abstract][Full Text] [Related]
33. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of high-risk human papillomavirus infection and cervical cytology abnormalities among women up to age 40 in the Tuzla Canton, Bosnia and Herzegovina.
Sadiković A; Iljazović E; Konrad Čustović M; Karasalihović Z; Avdić S
Acta Dermatovenerol Alp Pannonica Adriat; 2020 Dec; 29(4):175-179. PubMed ID: 33348936
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.
Zhao C; Austin RM
Gynecol Oncol; 2007 Nov; 107(2):231-5. PubMed ID: 17854873
[TBL] [Abstract][Full Text] [Related]
37. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
38. Community-Based Screening for Cervical Cancer: A Feasibility Study of Rural Appalachian Women.
Crosby RA; Hagensee ME; Vanderpool R; Nelson N; Parrish A; Collins T; Jones N
Sex Transm Dis; 2015 Nov; 42(11):607-11. PubMed ID: 26462184
[TBL] [Abstract][Full Text] [Related]
39. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
[TBL] [Abstract][Full Text] [Related]
40. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
